|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Symposium Report |
1 Department of Obstetrics and Gynecology, University of Cincinnati, College of Medicine, Cincinnati, OH 45267, USA
Fetal programming occurs when the normal pattern of fetal development is disrupted by an abnormal stimulus or insult applied at a critical point in in utero development. This then leads to an effect, for example diabetes or hypertension, which manifests itself in adult life. As the placenta is the regulator of nutrient composition and supply from mother to fetus and the source of hormonal signals that affect maternal and fetal metabolism, appropriate development of the placenta is crucial to normal fetal development. Placental function evolves in a carefully orchestrated developmental cascade throughout gestation. Disruption of this cascade can lead to abnormal development of the placental vasculature or of the trophoblast. Timing of a developmental insult will be critical in consequent placental function and hence programming of the fetus. The insults that alter placental development include hypoxia and abnormal maternal nutrient status, to which the placenta may adapt by alterations in transporter expression and activity to maintain fetal growth or by epigenetic regulation of placental gene expression. Hypoxia is physiological for organogenesis and placental tissue normally exists in a relatively hypoxic environment, but intrauterine growth restriction (IUGR) and pre-eclampsia are associated with a greater degree of trophoblast hypoxia. The metabolic activity of placental mitochondria leads to oxidative stress even in normal pregnancy which is exacerbated further in IUGR, diabetic and pre-eclamptic pregnancies and may also give nitrative stress known to lead to covalent modification and hence altered activity of proteins. Hypoxia, oxidative and nitrative stress all alter placenta development and may be a general underlying mechanism that links altered placental function to fetal programming.
(Received 8 January 2006;
accepted after revision 2 February 2006;
first published online 9 February 2006)
Corresponding author L. Myatt: Department of Obstetrics and Gynecology, University of Cincinnati, College of Medicine, PO Box 670526, Cincinnati, OH 45267, USA. Email: leslie.myatt{at}uc.edu
This article has been cited by other articles:
![]() |
D. A. Evseenko, P. Murthi, J. W. Paxton, G. Reid, B. S. Emerald, K. M. Mohankumar, P. E. Lobie, S. P. Brennecke, B. Kalionis, and J. A. Keelan The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction FASEB J, November 1, 2007; 21(13): 3592 - 3605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kar, D. Ghosh, and J. Sengupta Histochemical and morphological examination of proliferation and apoptosis in human first trimester villous trophoblast Hum. Reprod., November 1, 2007; 22(11): 2814 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Desai, D. Gayle, G. Han, and M. G. Ross Programmed Hyperphagia Due to Reduced Anorexigenic Mechanisms in Intrauterine Growth-Restricted Offspring Reproductive Sciences, May 1, 2007; 14(4): 329 - 337. [Abstract] [PDF] |
||||
![]() |
S. M. K. Alam, T. Konno, G. Dai, L. Lu, D. Wang, J. H. Dunmore, A. R. Godwin, and M. J. Soares A uterine decidual cell cytokine ensures pregnancy-dependent adaptations to a physiological stressor Development, January 15, 2007; 134(2): 407 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Nathanielsz and V. Padmanabhan Developmental origin of health and disease J. Physiol., April 1, 2006; 572(1): 3 - 4. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |